Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)
Johannesburg, South Africa--(Newsfile Corp. - May 7, 2020) - Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce the successful testing of its proprietary live cannabis plant extraction technology in conjunction with its joint venture partner, US-based Protext Pharma, Inc. (OTC Pink: TXTM). The testing took place over several days during the last couple months and involved various extract samples being produced under different conditions including...
2020-05-07 9:00 AM EDT
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology
Johannesburg, South Africa--(Newsfile Corp. - April 30, 2020) - Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce it has executed a letter of intent with USA-based Protext Pharma, Inc. (OTC Pink: TXTM), a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated from highly-bioavailable plant extracts. Under the terms of the agreement, the companies will form a joint venture partnership to (i) test...
2020-04-30 4:01 PM EDT